Lawyers Kemal Altuğ Özgün

Kemal Altuğ Özgün

Kemal Altuğ Özgün

CBC Law Firm

Altug is a legal and compliance professional with more than 19 years of experience. He started his career as a practicing lawyer at Ozgun Law Firm and then continues as an in-house counsel in multinational organizations. He served as Legal Counsel and a Board Member in Eastpharma (Deva Holding) then switched from pharma to medical devices in Beckman Coulter (a Danaher company) where he worked as Legal & Compliance Manager.

Altug continued his career as Head of Legal & Compliance at Sandoz (a Novartis division), where he focused primarily on legal department management, building and fostering the ethical culture and compliance program. Later, he decided to concentrate more on compliance and worked as an Ethics & Compliance Director at Astellas Pharma.

His practice focuses on third-party risk management, company law, labor law, healthcare regulations, anti-corruption law, employment law, white-collar crime, litigation, data privacy law, compliance, and competition law matters.


Practice Areas & Work Department

Compliance

Employment

Healthcare & Life Sciences

International Desk

 

Languages

English

Turkish

 

Memberships

Istanbul Bar Association

Ethics and Reputation Society (TEİD)

Artificial Intelligence and Technology Association (YZTD)

An Overview of Occupational Fraud 2024: A Report to the Nations by ACFE

The Association of Certified Fraud Examiners ("ACFE"), a global anti-fraud organization, has recently published its 2024 Occupational Fraud Report.

25.03.2024

EU Report: Antitrust Enforcement for Broader Pharmaceutical Access – Strengthening Compliance Amid Robust Measures

Explore the EU antitrust impact on pharmaceuticals (2018-2022). The recent report underscores the pivotal role of antitrust measures—promoting fair medicine prices, addressing anticompetitive practices, and shaping the future of pharmaceutical enforcement in Europe. In times of robust enforcement in both the EU and Türkiye, strategic compliance becomes imperative, providing pharmaceutical companies with a competitive edge.

23.02.2024

Unveiling the Shades of Integrity: 2023 Corruption Perceptions Index is Revealed

Transparency International's ("TI") 2023 Corruption Perceptions Index ("CPI") casts a revealing light on global and regional corruption trends. The index, which assesses perceived levels of public sector corruption in 180 countries and territories, has placed Denmark (90) at the top for the sixth consecutive year, followed by Finland and New Zealand with 87 and 85, respectively, while countries like Somalia (11), Venezuela (13), Syria (13), and South Sudan (13) rank at the bottom of the index this year.

01.02.2024

Binance Hakkındaki Soruşturma Rekor Ceza ile Sonuçlandı

Sanal para ticaretinin yüzde 60’ından fazlasını elinde tutan Sanal Döviz Borsası Binance, kendisine yöneltilen bir dizi suçlamayı kabul ederek, uygulanacak yaptırımlar konusunda ABD Hazine Bakanlığı ile anlaşmaya vardı. ABD Hazine Bakanlığı tarafından Mali Suçları Engelleme Ağı (“FinCEN”), Yabancı Varlıklar Kontrol Ofisi (“OFAC”) ve ABD Gelir İdaresi Cezai Soruşturma Birimi (“IRS-CI”) aracılığıyla yürütülen soruşturma, Banka Gizlilik Yasası’nın (“BSA”), kara para aklamayı önlemeye (“AML”) yönelik düzenlemelerin ve Amerikan ulusal güvenliğini ve uluslararası finansal sistemin bütünlüğünü koruyan yaptırım yasalarının ihlallerini içeriyor.

14.12.2023

An Interview with CBC Law Discussing Anti-Corruption in Turkey - Part 2

Yes. In particular, money laundering-related investigations and prosecutions with the involvement of high-profiles may require extensive cooperation and exchange of information and evidence with foreign authorities. Generally, the authorities contact the foreign public and private institutions through letters related to international anti-corruption cases, asking to freeze the perpetrator’s assets.

23.11.2023

An Interview with CBC Law Discussing Anti-Corruption in Turkey - Part 1

The cost of non-compliance is great. If you think compliance is expensive, try non-compliance’, US Deputy Attorney General Paul McNulty. This is applicable to all jurisdictions and companies operating in Turkey.

16.11.2023

Providing the Greatest Wealth in a Lawful Manner: Medical Tourism and Health Tourism in Türkiye – Healthcare Series 21

In this article, Altuğ and İdil explore the legal and ethical dimensions of Türkiye's booming medical tourism industry. Covering topics from accreditation and government support to legal challenges and dispute resolution, the article delves into the complexities of this dynamic sector.

25.10.2023

Türkiye's Thriving Cosmetics Industry: Opportunities, Challenges and Regulatory Insights – Healthcare Series 20

Türkiye's role as a connecting point between leading European cosmetics companies and the high-demand markets of Asia and the Middle East cannot be overstated. With its geographical location, trade relations with neighboring countries, and a population of over 85 million, Türkiye has a competitive edge in cosmetics and huge market potential. In support of this, Türkiye, which is in the top 30 among the World Cosmetics Importers in 2023, also has an average growth rate of 10% annually in the cosmetics market.[1] While cosmetic products are primarily intended for non-medical purposes, their application to the human body necessitates regulatory oversight within the cosmetics industry. This is essential to safeguard human health and maintain ethical standards in commercial marketing and advertising practices.

29.09.2023
Load More
Ready to stay ahead of the curve?
Share your interest anonymously and let us guide you through the informative articles on the hottest legal topics.
|
Successful Your message has been sent